ENTITY
Sanofi ADR

Sanofi ADR (SNY US)

87
Analysis
Health CareUnited States
Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
more
01 Dec 2020 09:34

Pre-IPO Harbour Biomed (2142.HK) - Don't Ignore The "Hidden Value"

This article analyzed Harbour's core products, team, technology platforms, thoughts on valuation and the "hidden" value that is often easy to be...

Logo
324 Views
Share
21 Oct 2020 02:00

Jacobio Pharma: Focus on Novel Targets

An in-depth overview of the proposed listing of Jacobio Pharmaceuticals using a framework that touches on the science, market opportunity,...

Share
20 May 2020 15:25

SK Biopharm IPO Industry Analysis & Contract Details

In this insight, we provide further details on the SK Biopharmaceuticals (BIO SK) IPO, including the industry and competitive analysis. We have...

Logo
227 Views
Share
bearishS&P 500 INDEX
31 Mar 2020 21:34

U.S. Equities: Test Of The Lows Coming?

Now that the initial/primary low has been established and with the S&P 500 roughly 20% off the lows, we believe it is time to map out potential...

Logo
352 Views
Share
09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
390 Views
Share
x